Physician profile
Emily Pike
NPI 1619385291
$3,095.45
in general payments reported to CMS, 2019-2025
18 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $474 · 2021: $268 · 2022: $587 · 2023: $540 · 2024: $442 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,401.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $671.16 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Coopervision INC. | $481.23 | 2019-2024 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $391.55 | 2019-2025 | Acuvue |
| Allergan, INC. | $359.29 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $285.42 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $231.02 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $184.84 | 2020-2025 | Tryptyr |
| Synergeyes, INC. | $108.00 | 2020-2021 | |
| Lkc Technologies, INC. | $98.98 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $68.73 | 2023 | Acthar |
| The Cameron-Ehlen Group, INC. | $43.22 | 2020 | |
| Sun Pharmaceutical Industries INC. | $35.41 | 2022-2024 | |
| Biotissue Holdings INC. | $35.04 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $31.10 | 2019-2020 | |
| Abbvie INC. | $27.17 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $15.61 | 2023 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $14.15 | 2021 | |
| Dompe US, INC. | $13.53 | 2024 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Pike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.